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B cell receptor (BCR) cross-linking induces B cell proliferation and sustains survival through 
the phosphorylation-dependent signals. We report that a loss of the protein phosphatase 
component G5PR increased the activation-induced cell death (AICD) and thus impaired B 
cell survival. G5PR associates with GANP, whose expression is up-regulated in mature B cells 
of the peripheral lymphoid organs. To study G5PR function, the 
 
G5pr
 
 gene was conditionally 
targeted with the CD19-
 
Cre
 
 combination (
 
G5pr
 
 
 
/
 
 
 
 mice). The 
 
G5pr
 
 
 
/
 
 
 
 mice had a decreased 
number of splenic B cells (60% of the controls). 
 
G5pr
 
 
 
/
 
 
 
 B cells showed a normal 
proliferative response to lipopolysaccharide or anti-CD40 antibody stimulation but not to 
BCR cross-linking with or without IL-4 in vitro. 
 
G5pr
 
 
 
/
 
 
 
 B cells did not show abnormalities 
in the BCR-mediated activation of Erks and NF-
 
 
 
B, cyclin D2 induction, or Akt activation. 
However, 
 
G5pr
 
 
 
/
 
 
 
 B cells were sensitive to AICD caused by BCR cross-linking. This was 
associated with an increased depolarization of the mitochondrial membrane and the 
enhanced activation of c-Jun NH
 
2
 
-terminal protein kinase and Bim. These results suggest 
that G5PR is required for the BCR-mediated proliferation associated with the prevention of 
AICD in mature B cells.
 
Antigen (Ag) binding to the specific B cell
receptor (BCR) triggers a series of multiple
signal transduction pathways by the initial ac-
tivation of tyrosine kinase Lyn, which thus
causes the phosphorylation of the BCR com-
plex comprised of the membrane form IgM
and its accessory molecules Ig
 
 
 
 and Ig
 
 
 
 (1–
3). The tyrosine phosphorylation of molecules
with SH2 domains, including Lyn and Syk
tyrosine kinases, leads to the activation of the
adaptors and the enzymes involved in the cas-
cade reactions of various signal transduction
pathways (4–6). Recent experiments have
suggested that the BCR signals for cell prolif-
eration are organized as major signal trans-
duction pathways via Ras/MEK-dependent
Erk activation and Carma-1–dependent NF-
 
 
 
B
up-regulation leading to C-myc/Stat5 activa-
tion, both of which ultimately induce cyclin
D2 activation (7).
BCR cross-linking also activates signal
transduction pathways involved in both the in-
hibition of apoptosis and the activation-induced
cell death (AICD) (8–10), which are potentially
associated with the selection and maintenance
of Ag-reacted B cells during the maturation
process in the germinal center (GC). The
BCR-mediated signals induce the survival of
B cells, which is a process associated with the
activation of Akt (11–13). Conversely, BCR-
mediated signals induce B cell apoptosis
through the alterations of Bcl-2, Bcl-X
 
L
 
, and
mitogen-activated protein kinases (MAPKs),
thus resulting in the activation of caspase-3,
caspase-7, and poly(ADP-ribose) polymerase
(14–16). Recent studies suggest that the depo-
larization of the mitochondrial membrane
potential (
 
  
 
m) is an essential event in the
BCR-mediated apoptosis of immature (bone
marrow) and mature GC–B cells (14, 17–19).
The alteration of 
 
  
 
m depends on the nascent
synthesis of the proteins involved in the per-
meability change of the mitochondrial mem-
brane (13, 17, 20). Mitochondrial dysfunction
initiates the release of cytochrome c and Apaf-1,
thus leading to the activation of caspases,
which are cysteine proteases associated with
apoptosis (21).
 
The online version of this article contains supplemental material.
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To investigate the BCR-mediated signals of mature B
cells, we studied the function of the protein phosphatase
(PP) component G5PR. The 
 
G5pr
 
 gene was identified by
the yeast two-hybrid screening method (22) as an associated
component of GANP that is up-regulated in GC–B cells
(23–25). G5PR binds not only to GANP but also to the
catalytic subunit of PP2Ac and PP5. G5PR is homologous
to the regulatory subunit of PP2A, carrying the region of
the EF hand that serves as a Ca
 
2
 
 
 
-binding motif. To study
the function of G5PR in
 
 
 
the regulation of B cell prolifera-
tion and differentiation, we prepared gene knockout
(
 
G5pr
 
 
 
/
 
 
 
) mice by conditional targeting in B cells with a
combination of the floxed-
 
G5pr
 
 gene and CD19-
 
Cre
 
–
knock-in mice. 
 
G5pr
 
 
 
/
 
 
 
 mice showed a deficit in the
BCR-mediated signal transduction associated with B cell
survival, which may imply a unique regulatory mechanism
of BCR-mediated signal transduction in mature B cells of
the peripheral lymphoid organs.
 
RESULTS
CD19-Cre–mediated B cell specific inactivation of 
 
G5pr
 
The 
 
loxP
 
 sequences were introduced upstream of exon I and
downstream of exon II by a homologous DNA recombina-
tion (Fig. 1 A). Southern blot analysis showed the 
 
loxP
 
 sites
to be targeted at the 
 
G5pr
 
 locus of the floxed (8.9 kb) band
in comparison with that of wild type (1.8 kb; Fig. 1 B). The
mice carrying a floxed 
 
G5pr
 
 allele (
 
G5pr
 
F/wt
 
) were crossed
with CD19-
 
Cre
 
 mice to obtain CD19-
 
Cre
 
/
 
G5pr
 
F/F
 
 (
 
G5pr
 
 
 
/
 
 
 
)
and littermate CD19-
 
Cre
 
/
 
G5pr
 
F/wt
 
 (
 
G5pr
 
 
 
/
 
 
 
) mice in order
to compare B cell activation. The gross appearance and
growth of 
 
G5pr
 
 
 
/
 
 
 
 mice were apparently normal. The ge-
nomic DNAs, obtained from splenic B cells by MACS sort-
ing, showed the alleles of wild-type (11.8 kb), targeted (F;
8.9 kb), and deleted (
 
 
 
; 4.5 kb) bands with probe A in a
Southern blot analysis with 
 
Hin
 
dIII digestion (Fig. 1, A and
C). 
 
G5pr
 
 
 
/
 
 
 
 B cells did not show any 
 
G5pr
 
 transcripts (Fig.
1 D), thus indicating that the mutant mice lacked the 
 
G5pr
Figure 1. Generation of a CD19-Cre–mediated G5PR-deficient 
mouse. (A) Targeting of the G5pr gene. (top model) Genomic organization 
of the G5pr gene locus (WT). H, HindIII; S, SalI. The bar indicates the probe 
used for Southern blots. The loxP sites are indicated by triangles. (bottom 
models) The targeting vector, the targeted allele (F), and the deleted allele 
( ). The G5pr-deleted allele was generated by the Cre-mediated deletion 
of loxP-flanked exons I and II. Correct targeting was verified by a Southern 
blot analysis of HindIII-digested DNAs with the indicated probe. Lengths 
of the respective HindIII fragments are shown. DT-A represents a selection 
cassette for diptheria toxin-A. (B) Germ line transmission of a G5pr-targeted 
allele. Tail DNAs from wild-type and G5prF/wt littermates were digested 
with HindIII, followed by Southern blot analysis. (C) CD19-Cre–mediated 
deletion of exons I and II flanked with loxP sites. DNAs of splenic B cells 
purified from G5pr /  and G5pr /  littermates were digested with HindIII, 
followed by a Southern blot analysis. (D) CD19-Cre–mediated disruption 
of the G5pr gene. RNA was extracted from splenic B cells isolated from 
G5pr /  and G5pr /  littermates and subjected to RT-PCR using exons 
spanning specific primers designed from exons II and IV of the G5pr gene. 
(E) Spleens from G5pr /  and G5pr /  mice. (F) Columns show mean cell 
numbers of total nucleated cells, B cells, and T cells in the spleens. The 
number of cells was calculated based on the proportion of B cells and 
T cells determined as B220  and CD3 , respectively. Error bars represent 
SEM. A significant difference in cell numbers between G5pr /  and G5pr /  
mice was indicated (P   0.01). 
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Figure 2 (continues on next page)
 
Figure 2. B cell development in 
 
G5pr
 
 
 
/
 
 
 
.
 
 (A) Flow cytometric analysis 
of cells from the bone marrow, spleen, axillary lymph node, peritoneal 
cavity, and peripheral blood. The numbers indicate the relative percent-
ages of cells within the indicated gates. Bone marrow contains (top) pro–B 
cells (B220
 
 
 
 CD43
 
 
 
), pre–B cells and immature B cells (B220
 
Low
 
 CD43
 
 
 
), 
and mature recirculating B cells (B220
 
High
 
 CD43
 
 
 
) and (middle) pro–B 
cells and pre–B cells (B220
 
 
 
 IgM
 
 
 
 IgD
 
 
 
), immature B cells (B220
 
 
 
 IgM
 
 
 
 
IgD
 
Low/
 
 
 
), and mature recirculating B cells (B220
 
 
 
 IgM
 
 
 
 IgD
 
High
 
). The 
spleen contains (top) B cells (B220
 
 
 
) and T cells (CD3
 
 
 
); (middle) transi-
tional type-1 B cells (IgM
 
High
 
 IgD
 
Low/
 
 
 
), transitional type-2 B cells (IgM
 
High
 
 
IgDHigh), and mature B cells (IgMLow IgDHigh); and (bottom) marginal zone 
B cells (CD21High CD23Low/ ) and follicular B cells (CD21  CD23 ). The 
lymph node contains (top) B cells (B220 ) and T cells (CD3 ) and (bot-
tom) transitional type-2 B cells (IgMHigh IgDHigh) and mature B cells 
(IgMLow IgDHigh). The peritoneal cavity contains B-1a cells (CD5  IgM ) 
and the peripheral blood contains B cells (B220 ) and T cells (CD3 ). 
transcription in the splenic B cells. The spleen was small in
G5pr /  mice and the B220  B cell population decreased to
approximately half that of the littermate G5pr /  mice (P  
0.01; (Fig. 1, E and F).
Reduction in the number of mature B cells in G5pr /  mice
CD19 is expressed on late pro–B cells and BCR  B cells. We
evaluated the B cell development in lymphoid organs of
G5pr /  mice. In the bone marrow, the proportion of pro–B
cells (B220Low CD43 ) was relatively high but that of pre–B
cells and immature B cells (B220Low CD43 ) decreased from
31 to 22.7% of the control B cells. The mature B cell
(B220High CD43 ) population was as low as 2.72% in G5pr / 
mice ( 50% of the control littermate G5pr /  mice). The
recirculating B cells with the IgM  IgD  phenotype also de-
creased (from 13.4 to 7.04%; Fig. 2 A). In the spleen, the
proportion of B cells dropped considerably (from 48.3 to
35.3%), and the T cell population increased (from 39 to
49.9%; Fig. 2 A). The maturation of B cells was affected in
G5pr /  mice. The mature B cell (IgMLow IgDHigh) popula-
tion decreased more remarkably (from 31.3 to 20.8%) than
the transitional-2 (IgMHigh IgDHigh) B cell population (from
9.88 to 7.08%). Transitional-1 (IgMHigh IgDLow) B cells, as a
newly migrated population from the bone marrow, were less
affected or even tended to increase (from 3.5 to 5.38%) in
G5pr /  mice, thus suggesting different sensitivities to the
defect of G5PR in these B cell populations. In addition,
G5pr /  mice showed a decrease (from 40 to 27.1%) in the
number of follicular mature B cells (B220  CD21Int
CD23High). The B cells decreased in the mature B cell popu-
lation of the axillary lymph node (from 16.4 to 9.33%) and
the peripheral blood (from 51.3 to 18.1%) of G5pr /  mice
(Fig. 2 A). These results suggested that the G5PR deficiency
affected the maturation or life span of B cells in the periphery.
Many gene knockout mice lacking B cell signal–related mol-
ecules displayed an abnormal CD5  B-1a cell development
in the peritoneal cavity (26–29). Likewise, G5pr /  mice
showed a decrease of B-1a (IgM  CD5 ) cells (from 17.2 to
10.5%), thus suggesting that G5PR is also necessary for the
differentiation of B-1a cells or their maintenance.
Antibody (Ab) responses of G5pr /  mice
G5pr /  mice did not show any abnormalities in serum Igs
of various classes in comparison with the control littermates
under nonimmunized conditions (Fig. 2 B), nor did they
display an impairment in Ag-specific IgM responses againstPOSITIVE REGULATOR FOR B CELL SURVIVAL | Xing et al. 710
Figure 2 (continued from previous page)
(B) Ig levels of various classes were measured by ELISA with the serum of 
nonimmunized mice. Specific Ab responses were measured after immuni-
zation with either TI-II Ag (C) or TD Ag (D). TNP-specific Abs were measured, 
and the results for TI-II Ag (IgM and IgG3) and TD Ag (IgM and IgG1) are 
shown. Horizontal lines represent mean Ab titers. (E) Immunization with 
TD Ag and SRBCs created GCs in the spleen comparable with those in 
control mice. The spleen sections were studied with G5PR2/2 mice (b, d, 
and f) in comparison with those of control mice (a, c, and e). Higher mag-
nification images, outlined by boxes in panels a and b, show control mice 
(c and e) and mutant mice (d and f). PNA  GCs (brown), IgD  B cells (blue), 
B220  B cells (brown), and CD4  T cells (blue) are shown. Arrows indicate 
typical GCs, and asterisks indicate extrafollicular regions. TZ, T cell zone; 
FO, follicular region.
both TNP-Ficoll and TNP–keyhole limpet hemocyanin
(Fig. 2, C and D). However, the IgG responses against both
Ags were slightly decreased in the G5pr /  mice at 14 d after
immunization. The GC formation examined after immuni-
zation with sheep RBCs (SRBCs) showed that G5pr / 
mice displayed similar numbers of lymphoid follicles withJEM VOL. 202, September 5, 2005 711
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IgD  B cells at 10 d, whereas the size of each mature PNA 
GC area was small (Fig. 2 E, b and d). The number of IgD 
B cells decreased in the extrafollicular regions of the spleens
in these mice (Fig. 2 E, as indicated by asterisks in b and d in
comparison with the control mice in a and c). In contrast,
the T cell zones appeared to be normal (Fig. 2 E, e and f).
Impaired cell proliferation of G5pr /  B cells induced by BCR 
cross-linking
The B cell proliferation activity was measured in vitro after
stimulation with anti-IgM Ab or LPS. BCR cross-linking
could not induce the proliferation of G5pr /  B cells over a
wide range of Ab concentrations in comparison with the con-
trol G5pr /  B cells, and the addition of 100 U/ml IL-4 did
not cause the proliferation of G5pr /  B cells to recover at 48 h
after stimulation (Fig. 3 A, left); however, LPS stimulation
induced the proliferation of G5pr /  B cells at a comparable
level to that of control B cells (Fig. 3 A, right). The lower re-
sponse of the G5pr /  B cells was not caused by the different
kinetics of cell proliferation (Fig. 3 B). The peak thymidine
incorporation was observed at 48 h after BCR cross-linking in
both G5pr /  and control B cells. No marked difference was
found between the control B cells of G5pr /  and wild-type
mice. These results suggested that a loss of G5PR impaired
BCR-induced cell proliferation or survival, which was not
completely compensated by IL-4 costimulation.
No apparent alteration of BCR-mediated signal transduction 
pathways of B cell proliferation
We examined the alteration of the BCR-mediated signal
transduction for B cell proliferation in vitro. BCR cross-
linking induced an up-regulation of the activation markers
CD25 and CD69 on G5pr /  B cells quite similarly to the
levels of the control B cells (Fig. 4 A). The BCR signaling
cascade leading to cell activation is initiated by the activation
of tyrosine kinase and the tyrosine phosphorylation of vari-
ous secondary signal transduction molecules (1, 4, 5, 30–32).
G5pr /  B cells caused a normal tyrosine phosphorylation
reaction after BCR cross-linking in vitro and there was no
apparent difference in the entire tyrosine phosphorylation
profile between G5pr /  and G5pr /  B cells that would ac-
count for the impairment in BCR-induced cell proliferation
(Fig. 4 B). The initial tyrosine phosphorylation induces
PLC- 2 activation, which thus induces the downstream sig-
nal transduction pathways involved in protein kinase C acti-
vation, subsequently leading to generation of Ca2  flux.
G5pr /  B cells showed a normal level of Ca2  flux both in
amplitude and duration (Fig. 4 C). These results demon-
strated that the proximal events of BCR-mediated signaling
appeared normal in G5pr /  mice.
The activation of the MAPK pathway (Erk1 and Erk2) is
essential for the BCR-mediated signal transduction leading to
B cell proliferation (33). Both Erk1 (p44) and Erk2 (p42)
Figure 3. B cell proliferation in response to the mitogenic stimuli 
in vitro. (A) Splenic B cells were cultured for 48 h in the presence of 
medium alone, anti-IgM F(ab’)2 Ab, or 100 U/ml IL-4 (left) or LPS (right). 
B) Kinetics of the responses of WT, G5pr / , and G5pr /  B cells to anti-
IgM Ab indicated a similar response curve with the peak at 48 h after 
stimulation. [3H]thymidine was added for the final 6 h. The results are 
representatives of three experiments performed in triplicate. The incorporation 
of [3H]thymidine is shown as counts per min (cpm) with the SD of the 
triplicate culture samples per each.POSITIVE REGULATOR FOR B CELL SURVIVAL | Xing et al. 712
were promptly phosphorylated at 1 min after the BCR cross-
linking of G5pr /  B cells (Fig. 4 D). There was also no dif-
ference in the Erk protein expression. BCR cross-linking in-
duces the activation of PI3K, which regulates downstream
signal transductions through the interaction with Gab-1 and/
or BCAP (34, 35). PI3K is upstream of Akt and NF- B, and
these pathways are implicated in the inhibition of BCR-
mediated apoptotic signals (36–38). We investigated whether
the impairment of cell proliferation by BCR cross-linking was
attributed to the disruption of these two pathways in G5pr / 
B cells; however, the B cells showed normal responses of Akt
phosphorylation to BCR cross-linking (Fig. 4 E). Similarly,
the NF- B pathway assessed by I B degradation showed no
change in comparison with G5pr /  B cells. The major
downstream target of these signals is cyclin D2, which pro-
motes the cell cycle progression of B cells (7). BCR cross-
linking induced cyclin D2 and phosphorylation of Rb in
G5pr /  B cells at levels comparable with control B cells (Fig.
4 F), thus indicating that G5pr /  B cells did not show obvi-
ous defects in the above-mentioned BCR-mediated signal
transduction pathways involved in B cell proliferation.
G5PR is associated with PP2Ac as one of the possible
components for phosphatase regulation or for target specific-
ities (22). The phosphatase activity was measured with the
synthetic substrate using the PP2Ac immunoprecipitate from
B cells after BCR cross-linking for 1 h. The PP2A activities
were slightly lower in the G5pr /  B cells than in the con-
trol B cells (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20050637/DC1). Usually, it is rare to de-
tect a clear difference in the PP2A activity in lymphocytes
because of a low expression of phosphatases (39) and the
presence of multiple regulatory subunits, which often disturb
the identification of selective regulatory activity for various
target molecules.
Enhanced BCR-mediated apoptosis in G5pr /  B cells
We evaluated the mortality of B cells in vitro to examine
whether the poor proliferation of G5pr /  B cells after BCR
Figure 4. BCR-mediated signaling in G5PR-deficient B cells. (A) The 
activation of G5pr /  and G5pr /  B cells in response to 10  g/ml anti-IgM 
F(ab’)2 Ab as assessed by the up-regulation of CD25 and CD69. Histograms 
represent CD25 or CD69 expression with (black plot) and without (white 
plot) stimulation. (B) A Western blot analysis for tyrosine-phosphorylated 
proteins. The isolated splenic B cells from G5pr /  and G5pr /  littermates 
were stimulated with anti-IgM F(ab’)2 Ab. Cell lysates were subjected to 
Western blotting with antiphosphotyrosine Ab (4G10) and reprobed with 
anti– -actin Ab for controls. (C) A calcium Flux analysis in response to 
BCR cross-linking. A flow cytometry analysis depicting calcium flux (y axis) 
as a function of time (x axis) in the cells stimulated with 10  g/ml anti-IgM 
F(ab’)2 Ab. The arrow indicates the time point of stimulation. (D) BCR-induced 
Erk phosphorylation was monitored by a Western blot analysis using 
phosphorylated Erk-specific Ab. The entire Erk expression was also moni-
tored as an internal control. Erk1 (p44) and Erk2 (p42) were indicated. 
(E) Time course of Akt phosphorylation and the degradation of I B . 
(F) BCR cross-linking–dependent expression of cyclin D2 and phosphorylation 
of Rb. The phosphorylated Rb was detected as shifted bands because of a 
slower mobility than nonphosphorylated Rb. 106 B cells were stimulated 
with 10  g/ml anti-IgM F(ab’)2 Ab. Each membrane was reprobed with 
anti– -actin Ab as control.JEM VOL. 202, September 5, 2005 713
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cross-linking was caused by the alteration of B cell survival.
G5pr /  B cells showed a reduction in the number of live
cells at 6 h after BCR cross-linking in comparison with the
control G5pr /  B cells. The reduction became more obvi-
ous at 24 h after stimulation (from 68.2 to 35.1%; Fig. 5 A).
The fraction containing both annexin V single-positive cells
(early phase) and annexin V/7-amino-actinomycin D dou-
ble-positive cells (late phase) increased from 15.3 to 33.8%
during the stimulation of G5pr /  B cells for 24 h (Fig. 5 B).
Notably, G5pr /  B cells did not show any difference in
the spontaneous cell death (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20050637/DC1). On
the other hand, LPS prevented the cell death of G5pr /  B
cells in a manner similar to that of control G5pr /  B cells
(Fig. 5, A and B). We thus conclude that the hypoprolifera-
tion of G5pr /  B cells resulted from an increased suscepti-
bility to BCR-mediated AICD.
Increased mitochondrial membrane depolarization induced 
by BCR cross-linking in G5pr /  B cells
We examined the DNA fragmentation of G5pr /  B cells
by propidium iodide staining. The number of dead cells in-
creased  6 times in G5pr /  B cells in comparison with the
control B cells at 24 h after BCR cross-linking, as measured
by the subdiploid fraction (from 1.12 to 6.61%; Fig. 6 A).
Next, we investigated the mitochondrial membrane depo-
larization of B cells after stimulation as an early event of
apoptosis, which subsequently increases mitochondrial
membrane permeability and facilitates the release of the
proapoptotic factor cytochrome c from the mitochondria
into the cytosol and is followed by caspase-3 activation (40).
A fluorescent dye (DiOC6) that binds to the mitochondrial
membrane in living cells was used for the initial change.
BCR cross-linking induced membrane depolarization
(43%), which was higher than that observed after LPS stim-
ulation (15.5%), in the control G5pr /  B cells. In compar-
ison with the controls, G5pr /  B cells showed much more
change (64%) by BCR cross-linking, thus indicating that a
lack of G5PR augmented the susceptibility to the BCR-
mediated signal transduction, thereby leading to a reduction
in   m (Fig. 6 B).
The single-strand and double-strand DNA breaks were
measured using a Tdt-mediated dUTP-biotin nick-end la-
beling (TUNEL) assay in vitro. TUNEL-positive cells were
induced by BCR cross-linking at higher levels in G5pr /  B
cells in comparison with control B cells (32.2 vs. 21.1% at
24 h after stimulation), but were not by LPS stimulation
(15.9 vs. 13.8%; Fig. 6 C).
Figure 5. Cell death of G5PR-deficient B cells. Splenic B cells from 
either G5pr /  or G5pr /  mice were stimulated with 10  g/ml anti-IgM 
F(ab’)2 Ab. (A) Living cells were identified with forward scatter (FSC) and 
side scatter (SSC) on the FACS profile. (B) Apoptotic cells were monitored 
as annexin V–FITC positive cells. Lymphoid gating was set by the parameters 
of SSC and FSC. The number in each box indicates the percentage of cells 
in that box based on the gated sample.POSITIVE REGULATOR FOR B CELL SURVIVAL | Xing et al. 714
Caspase-3 is involved in the BCR-mediated cell death
pathways in the immature B cell line WEHI-231 (20, 41–
43). We attempted to measure the change in the caspase-3–
dependent cell death pathway by detecting the active caspase-3.
Anti-Fas Ab induced caspase-3–positive cells (49.1%) as a
positive control (Fig. S3, available at http://www.jem.org/
cgi/content/full/jem.20050637/DC1). However, we did not
observe any increase of the active caspase-3 in G5pr /  B
cells by BCR cross-linking for 6 h (3.51%) and 24 h (2.01%;
Fig. S3). This was also the case in the control B cells. Only
3.56% of the control B cells showed active caspase-3, which
was estimated to be from 5 to 9% of mitochondrial mem-
brane–depolarized cells (43%). These results suggest that
BCR-mediated AICD is not dependent on the caspase-3–
mediated pathway in mature B cells.
Prolonged Bim activity and enhanced c-Jun NH2-terminal 
protein kinase (JNK) activity in G5pr /  B cells after 
BCR cross-linking
Mitochondrial integrity has been proposed to be regulated
by the pro- and antiapoptotic members of the Bcl-2 family.
The Bcl-2 proteins maintain a balance between the specific
homo- and heterodimers for cell survival and the induction
of apoptosis on stimulation. BCR cross-linking induces anti-
apoptotic Bcl-XL and Bcl-2, which play a prominent role in
the protection of mature B cells from AICD (44, 45). The
transgenic mice of Bcl-XL and Bcl-2 displayed an increased
number of B cells in vivo (46–48). We investigated whether
the decreased survival of G5pr /  B cells was caused by the
down-regulation of Bcl-2 and Bcl-XL. BCR cross-linking
induced the up-regulation of Bcl-XL in both the control and
G5pr /  B cells, which demonstrated comparable levels with
the shift in the size at 24 h after stimulation (Fig. 7 A). A
down-regulation of the Bcl-2 expression after BCR cross-
linking was nearly equivalent between the control and
G5pr /  B cells (Fig. 7 A) (49).
BH3-only proteins have been reported to induce Bax-
and Bak-dependent apoptosis under environmental stress
(50). Among the BH3-only proteins, Bim has been shown
to play a crucial role in the cell death signal induced by BCR
cross-linking. Bim /  mice showed a 2–3-fold increase in B
cell number (51). The Bim /  B cells were refractory to the
Figure 6. Mitochondrial apoptotic machinery in G5PR-deficient B 
cells. (A) 106 B cells stimulated either with 10  g/ml anti-IgM F(ab’)2 Ab or 
10  g/ml LPS for 24 h were lysed in hypotonic buffer containing propidium 
iodide, and nuclear DNA contents were analyzed. The number in each box 
indicates the percentage of cells in that box based on the gated sample. 
(B) For the quantitation of   m, 106 splenic B cells were stimulated either 
with 10  g/ml anti-IgM F(ab’)2 Ab or 10  g/ml LPS for 24 h and subjected 
to staining with the   m-sensitive dye DiOC6. The proportion of depolar-
ized cells is shown by the percentage in the histogram. (C) 106 splenic B 
cells were stimulated with anti-IgM F(ab’)2 Ab or LPS and were harvested 
and characterized by TUNEL assay. FITC-dUTP–incorporated cells were 
measured by flow cytometry. The number in each box indicates the 
percentage of cells in that box based on the gated sample.JEM VOL. 202, September 5, 2005 715
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apoptosis induced by BCR cross-linking in vitro (49).
Therefore, we examined whether the expression and/or
phosphorylation of Bim on BCR cross-linking was affected
in the absence of G5PR by Western blotting (Fig. 7 B). The
Bim phosphorylation was detected as p-Bim-EL with non-
phosphorylated Bim-EL, Bim-L, and Bim-S subunits. BCR
cross-linking induced the expression and phosphorylation of
Bim-EL at 6 h, but gradually suppressed their expressions af-
ter 12 h in control B cells. G5pr /  B cells showed a pro-
longed increase of the expression and phosphorylation of
Bim-EL. The increase was marked at 24 h and showed a
5.4-fold increase over the nonstimulated B cells, whereas the
control G5pr /  B cells showed a 2.2-fold increase. Bim-EL
mRNA was induced by BCR cross-linking, suggesting that
G5PR regulates the Bim expression also at the transcrip-
tional level (Fig. 7 C). These results indicated that a lack of
G5PR caused an abnormal continuation of the expression
and phosphorylation of Bim-EL during B cell stimulation by
BCR cross-linking, which potentially could lead to a pro-
longed mitochondrial membrane destabilization.
JNK and p38, which belong to the MAPK family, have
been shown to be involved in the BCR-mediated AICD
pathway (52). JNK promotes cell death through the phos-
phorylation and activation of several proapoptotic Bcl-2
family members. In UV-induced apoptosis, JNK phosphory-
lates the BH-3–only protein Bim, which thus results in the
Bax/Bak-dependent activation of the mitochondrial apopto-
sis pathway (50). We examined the induction of JNK be-
tween the control and G5pr /  B cells. BCR cross-linking
induced the expression and phosphorylation of JNK at
higher levels in G5pr /  B cells, especially at 30 min,
whereas the induction of phosphorylation of p38 occurred
normally (Fig. 7 D). We evaluated the Bim phosphorylation
in the presence of the JNK-specific inhibitor SP600125. The
JNK inhibitor at 10  M suppresses the anti-CD40–induced
JNK activation, but this treatment caused severe B cell apop-
tosis after 24 h (unpublished data). We thus chose a dosage
of mild effect (2  M), which did not cause such severe cell
death but still suppressed the phosphorylation of JNK at 10
min after CD40 cross-linking (Fig. S4, available at http://
www.jem.org/cgi/content/full/jem.20050637/DC1). This
treatment did not cause any apparent difference in the Bim
phosphorylation in G5pr /  B cells (Fig. 7 E). Whether or
not JNK is the upstream regulator of Bim phosphorylation
still remains to be elucidated.
DISCUSSION
Mature B cells in peripheral lymphoid organs are triggered
by the signal through BCR, but the complete activation de-
pends on costimulatory signals provided in secondary lym-
phoid organs. BCR-mediated signal transduction uses non-
specific and common pathways that are involved in the
proliferation of many kinds of cells. Antigenic stimulation
presumably activates B cells through common pathways, but
Figure 7. BCR-mediated regulation of apoptotic and survival sig-
naling molecules in G5PR /  B cells. Expression of Bcl-XL or Bcl-2, 
expression and phosphorylation of Bim, the phosphorylation of JNK or 
p38, or expression and phosphorylation of Bim in the presence of JNK 
inhibitor were studied.  (A) The membrane was probed with anti–Bcl-XL or 
anti–Bcl-2 Ab.  (B) Three major isoforms of Bim—short type (S), large type 
(L), and extra-large type (EL)—were detected with anti-Bim Ab.  The relative 
intensities of the bands are shown based on the controls. 106 splenic B cells 
from both mutant and control mice were stimulated with 10 mg/ml anti-
IgM F(ab’)2 Ab for the time depicted in the figures.  To show the loading 
amounts, each membrane was reblotted with anti– -actin Ab.  (C) 106 
splenic B cells were stimulated with 10 mg/ml anti-IgM F(ab’)2 Ab, and 
total RNAs were isolated, converted to cDNA, and subjected to measure 
BimEL expression by RT-PCR.  (D) BCR-induced JNK and p38 phosphoryla-
tion was monitored with phospho-JNK or phospho-p38–specific Ab.  The 
entire JNK expression was monitored as an internal control.  JNK1 (p46) 
and JNK2 (p54) are indicated with arrows.  An asterisk indicates a nonspe-
cific band.  The relative intensities of bands were shown based on the 
controls.  (E) Splenic B cells were stimulated with 10 mg/ml anti-IgM 
F(ab’)2 Ab for 24 h after incubation with or without 2 mM SP600125 for 
30 min.  Bim induction and its phosphorylation were detected (B).POSITIVE REGULATOR FOR B CELL SURVIVAL | Xing et al. 716
precisely how the BCR-unique pathway modifies or affects
their response remains to be elucidated. Our results suggest
that the BCR-mediated signal transduction regulates B cell
survival through the phosphatase-binding protein G5PR.
We demonstrated that the target of G5PR was the BCR-
mediated transduction pathway involved in cell survival at
the regulation of JNK and Bim activation.
G5PR regulates the cell survival selectively in the BCR-
mediated induction of AICD. The loss of G5PR did not af-
fect the proliferation of B cells stimulated by either LPS or by
anti-CD40 stimulation in vitro. We did not find any abnor-
malities in the major B cell proliferation pathways leading to
the activation of cyclin D2, which also supported the hypoth-
esis that G5pr /  B cells could proliferate normally in re-
sponse to other stimulations. G5pr /  mice revealed a similar
phenotype to Bam32 /  and cyclin D2 /  mice (27, 28).
These mutant mice showed a marked hyporesponsiveness of
mature B cells to BCR-mediated proliferation but not to LPS
or anti-CD40 stimulation. The number of CD5  B-1a cells
in the peritoneal cavity decreased dramatically in these mice.
However, the target of G5PR is obviously different from
those described in of previous reports (27, 28). The most sen-
sitive pathway related to the loss of G5PR seemed to be the
JNK pathway, whose activity is strictly dependent on the
phosphorylation state as the serine/threonine-kinase cascade
(53, 54). The selective regulation of BCR-mediated JNK ac-
tivation might depend on the existence of G5PR in B cells.
This might explain the fine tuning of the amplitude of BCR-
mediated signal transduction, thus leading to the proliferation
and maintenance of B cells in the peripheral lymphoid organs.
Bcl-2 and Bcl-XL, antiapoptotic members of Bcl-2 family
proteins, were described to be both phosphorylated and inac-
tivated by JNKs in vivo (55, 56). The hyperactivation of JNK
caused an alteration of Bcl-2 and Bcl-XL, thus resulting in a
dysfunction of the mitochondria, including an altered respira-
tion, transmembrane potential, and calcium buffering capac-
ity; however, the expression and phosphorylation of Bcl-2
and Bcl-XL seemed to be largely normal in G5pr /  B cells.
The BH3-only protein Bim and its relatives appear to be
potential targets of JNK in the regulation of mitochondrial
apoptosis (57). Bim, which is expressed at high levels in human
leukocytes and spleens (58, 59), associates with the dynein light
chain of the microtubule-associated dynein motor complex
and are released from the complex by specific apoptotic stimuli
(60). In our study, JNK inhibitor could not provide the clear
evidence that the activation of JNK is the upstream signal for
Bim phosphorylation in BCR-mediated AICD.
Bim has been proposed to bind to Bak and Bax, thus
causing an allosteric conformational activation to promote
mitochondrial membrane depolarization (61). Recently,
Chen et al. demonstrated that the BH3 domain derived from
Bim physically interacted strongly with Bcl-2, Bcl-XL, Bcl-w,
Mcl-1, and A1 in vitro (62). These results suggested that
Bim promotes B cell apoptosis by the inactivation of the
prosurvival Bcl-2 family rather than the activation of Bak
and Bax, as supported by the functional analysis of Bim in
TCR signaling. Anti-CD3 cross-linking induces expression
of Bim-EL and –L and enhances their binding with Bcl-XL
in thymocytes (63), thus suggesting that Bim association in-
activates Bcl-XL in thymocytes, resulting in AICD. This no-
tion was supported by the finding that Bim /  thymocytes
were resistant to TCR-induced apoptosis (63).
Bim /  B cells were unresponsive to BCR-induced
apoptosis (49, 51). On the other hand, Bim overexpression
induces apoptosis by mitochondrial dysfunction in Apaf-1 / 
mouse embryonic fibroblast cells that lack caspase-9 or cas-
pase-3 activation (64). The Bcl-2–Bim–Bax/Bak pathway,
which is involved in the control of lymphocyte apoptosis
and survival at the level of the mitochondria, does not neces-
sarily trigger the effector caspase–dependent apoptotic path-
way, especially in mature spleen B cells. The caspase-3–
dependent pathway, as an effector protease, is presumably
inhibited by the normal activation of NF- B in G5pr /  B
cells, as demonstrated previously (65). Collectively, we hy-
pothesize that the prolonged Bim up-regulation is a major
cause of increased sensitivity to AICD in G5pr /  B cells.
G5PR might suppress kinases through the interaction with
PPs and/or regulate the expression of Bim. The augmented
Bim may induce vigorous disruption of the mitochondrial
function, thus resulting in AICD.
The mature B cell numbers markedly decreased in adult
G5pr /  mice, thus suggesting that B cell numbers in periph-
eral lymphoid organs were maintained by the signals depen-
dent on G5PR and, presumably, mediated through BCR.
This may provide information regarding the model proposed
by Cancro and Monroe in which the continuous triggering
of BCR by self-Ags is essential for the maintenance of the B
cell pool in peripheral lymphoid organs (66, 67). Based on
their model, B cells need to survive with the subthreshold
stimulatory signals that are continuously or intermittently
provided to either maintain or expand the B cell number in
peripheral lymphoid organs. Almost the entire B cell popula-
tion was depleted in adult mice at 10–20 d after inducible
surface IgM ablation, thus suggesting that the expression of
BCR is indispensable for B cell maintenance by transducing
the survival signal that promotes cell survival (68).
GC–B cells express a high level of Bim and Bax, proapop-
tosis players, thus indicating that they are at risk to undergo
cell death, which might be involved in the selection of Ag-
specific B cells. A possible site of B cell selection is the follic-
ular dendritic cell network expressing CR1, which can po-
tentially trap the Ag–Ab complex with complement C3d
(69, 70). The high-affinity BCR may well recognize the
complex and, thus, would readily receive a signal for the sur-
vival and proliferation of B cells with the help of such acces-
sory molecules as CD40 and Blys on the FDC (71). G5PR
might regulate another kinase molecule selectively expressed
in GC–B cells such as GCK, which is a member of the Ste20
family and selectively activates JNK (72, 73). Studies of such
GC–B cell specific molecules in G5pr /  mice would pro-
vide further information regarding the regulation of B cell
survival in the secondary lymphoid organs.JEM VOL. 202, September 5, 2005 717
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MATERIALS AND METHODS
Generation of G5prF/wt and CD19-Cre/G5prF/F mice. The CD19–
Cre–knock-in mouse was provided by R.C. Rickert (The Burnham Insti-
tute, La Jolla, CA). The G5pr-floxed mice were generated in collaboration
with N. Takeda (Kumamoto University, Kumamoto, Japan). All mice were
maintained in the Center for Animal Resources and Development (CARD)
at Kumamoto University. A targeting vector was designed to insert the loxP
sites and the neomycin-resistant gene Neor into the G5pr genomic locus, the
3  end of which contains the negative selection marker DT-A (Fig. 1 A).
The floxed 0.88-kb SalI/BglII fragment contains the ATG start codon. Ho-
mologous embryonic stem recombinants screened by PCR were confirmed
by Southern blot analysis with a 0.28-kb fragment of the 3  homologous
arm. Five G5prF/wt embryonic stem clones were injected into blastocysts
(Institute for Cancer Research), and the two independent chimeric males
were mated with C57BL/6 females to obtain G5prF/wt offspring. The het-
erozygous mutant mice were maintained for the C57BL/6 background.
PCR was performed using the neo2 primer (5 -GCCTGCTTGC-
CGAATATCATGGTGGAAAAT-3 ) and the 3  G5pr exon3 primer (5 -
ACCGGGGTATGGTCTTATAGAACTCGTTTG-3 ). B cell–specific,
G5PR-deficient (G5pr / ) mice were generated by crossing G5prF/F mice
with CD19–Cre–knock-in mice. Experimentation and animal care was in
accordance with the guidelines of the CARD at Kumamoto University.
RT-PCR. cDNAs synthesized using total RNAs were PCR amplified us-
ing primers from exons II and IV (5 -GGTTAGCGTCGCCCAACACG-
3  and 5 -GATTCCTCTCGTAATTTCTG-3 , respectively). For BimEL,
the primers 5 -CTACCAGATCCCCACTTTTC-3  and 5 -CAGCTC-
CTGTGCAATCCGTATC-3  were used (74).
B cell isolation. B cells were isolated by the depletion of CD43 , CD4 ,
and Ter-119  cells with magnetic beads (MACS; Miltenyi Biotec) and
were  90% B220 , as verified by flow cytometry.
Flow cytometric analysis. Lymphoid cells stained with anti-B220–PE,
anti-B220–APC, anti-CD3–biotin, anti-CD5–PE, anti-CD21–FITC, anti-
CD23–biotin, anti-CD25–PE, anti-CD69–FITC, anti-CD43–biotin, anti-
IgM–FITC, anti-IgD–PE, and Streptavidin PerCP-Cy5.5 (BD Biosciences)
were analyzed by FACSCalibur using CellQuest (Becton Dickinson) and
FlowJo (Tree Star, Inc.) software. The apoptosis-associated changes to the
plasma membrane were determined with annexin V–FITC and 7-amino-
actinomycin D (BD Biosciences).
Immune responses of mice to TI-II Ag and TD Ag. Mice were im-
munized peritoneally with TI-II Ag, TNP conjugated with Ficoll (25  g/
mouse; Southern Biotechnology Associates, Inc.) in PBS or TD Ag, and
TNP conjugated with keyhole limpet hemocyanin (20  g/mouse; South-
ern Biotechnology Associates, Inc.) in the Freund’s complete adjuvant. Se-
rum Igs were measured by ELISA (25). GCs and architectures of spleens
were examined with PNA-biotin (Vector), anti-IgD, anti-CD4, and anti-
B220–biotin after immunization with TD Ag and SRBCs for 10 d (23).
In vitro proliferation assay. 106 purified splenic B cells/ml in triplicate
were cultured for 48 h with anti-IgM F(ab )2 Ab (anti-IgM; ICN Biomedi-
cals), IL-4 (PeproTech), and the combination of these stimulants or LPS
(Sigma-Aldrich). 2  Ci/ml [3H]thymidine (ICN Biomedicals) was added
for the final 6 h.
Ca2  mobilization response. Splenic B cells loaded with 4  M Fluo-3/
AM (Dojindo) were stimulated with 10  g/ml goat anti-IgM Ab (ICN
Biomedicals), and the increase of intracellular Ca2  mobilization was re-
corded on live gated cells.
Western blotting. 106 splenic B cells/ml were stimulated with 10  g/ml
of anti-IgM Ab (ICN Biomedicals) and lysed in 1% TNE lysis buffer (1%
Nonidet P40, 150 mM NaCl, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 2
mM phenylmethylsulphonyl fluoride, 1  g/ml leupeptin, 1  g/ml pep-
statin and 1  g/ml aprotinin, 1 mM Na3VO4, and 10 mM NaF) (22). West-
ern blot analysis was performed with anti-phosphotyrosine Ab (4G10; Up-
state Biotechnology) and anti-Bim Ab (StressGen Biotechnology Associates,
Inc.). Anti-cyclin D2 and anti-I B  Abs were obtained from Santa Cruz
Biotechnology, Inc. Anti-Rb, anti-Bcl-XL, and anti–Bcl-2 Abs were ob-
tained from BD Biosciences. Each membrane was reprobed with anti– -
actin Ab (Sigma-Aldrich). The membranes were developed with Abs spe-
cific to phosphorylated proteins of Erk1/2, JNK1/2, p38, and Akt (Cell
Signaling Technology). SP600125 (Calbiochem) was used as a JNK inhibi-
tor. The membranes were incubated with the Ab to the nonphosphorylated
form of Erk1/2, JNK1/2, or  -actin (Sigma-Aldrich).
Analysis of DNA fragmentation and   m. 106 splenic B cells/ml
were stimulated with 10  g/ml of anti-IgM Ab (ICN Biomedicals) for 24 h,
stained with hypotonic DNA staining solution (50  g/ml propidium io-
dide, 0.1% sodium citrate, 0.1% Triton X-100), and analyzed. DiOC6
(3,3 -dihexyloxacarbocynine iodide; Molecular Probes) was added at a con-
centration of 40 nM, and the cells were incubated at 37 C for 30 min. The
DiOC6 fluorescence was measured at the FL1 channel.
TUNEL assay. TUNEL analysis for DNA fragmentation was performed
using an APODIRECT kit (BD Biosciences). Their double- or single-
strand DNA breakages were determined by flow cytometry after incorpora-
tion of FITC-dUTP with exogenous TdT.
Online supplemental material. Fig. S1 shows PP activity in G5pr /  B
cells. Fig. S2 depicts spontaneous blast formation and apoptosis in vitro. Fig. S3
caspase-3 activation in G5pr /  B cells on BCR cross-linking. Fig. S4 depicts
the effect of a JNK-specific chemical inhibitor. Online supplemental material is
available at http://www.jem.org/cgi/content/full/jem.20050637/DC1.
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